Perrigo Company (PRGO) Shares Sold by Magnetar Financial LLC
Magnetar Financial LLC decreased its holdings in Perrigo Company (NYSE:PRGO) by 84.3% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,804 shares of the company’s stock after selling 15,060 shares during the quarter. Magnetar Financial LLC’s holdings in Perrigo were worth $237,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also made changes to their positions in the stock. BB&T Securities LLC lifted its stake in Perrigo by 0.4% in the second quarter. BB&T Securities LLC now owns 9,062 shares of the company’s stock worth $684,000 after acquiring an additional 35 shares during the period. Arizona State Retirement System raised its holdings in Perrigo by 0.3% in the second quarter. Arizona State Retirement System now owns 35,600 shares of the company’s stock worth $2,689,000 after purchasing an additional 100 shares in the last quarter. State of Tennessee Treasury Department raised its holdings in Perrigo by 0.3% in the second quarter. State of Tennessee Treasury Department now owns 39,214 shares of the company’s stock worth $2,961,000 after purchasing an additional 103 shares in the last quarter. Sentry Investment Management LLC raised its holdings in Perrigo by 1.1% in the second quarter. Sentry Investment Management LLC now owns 11,028 shares of the company’s stock worth $833,000 after purchasing an additional 117 shares in the last quarter. Finally, Commonwealth Bank of Australia raised its holdings in Perrigo by 13.8% in the second quarter. Commonwealth Bank of Australia now owns 1,455 shares of the company’s stock worth $108,000 after purchasing an additional 176 shares in the last quarter. 85.53% of the stock is owned by institutional investors.
In other news, EVP John Wesolowski sold 388 shares of the firm’s stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $87.20, for a total transaction of $33,833.60. Following the completion of the transaction, the executive vice president now directly owns 248 shares in the company, valued at $21,625.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders have sold 1,051 shares of company stock valued at $89,810 over the last 90 days. Corporate insiders own 6.90% of the company’s stock.
Perrigo (NYSE:PRGO) last issued its quarterly earnings results on Thursday, November 9th. The company reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.28. Perrigo had a positive return on equity of 11.60% and a negative net margin of 26.28%. The firm had revenue of $1.22 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same period last year, the company earned $1.65 earnings per share. The company’s revenue was down 2.0% on a year-over-year basis. analysts expect that Perrigo Company will post 4.88 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 19th. Stockholders of record on Friday, December 1st will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $0.64 annualized dividend and a dividend yield of 0.74%. Perrigo’s payout ratio is presently -6.99%.
A number of equities analysts have issued reports on the company. Cantor Fitzgerald set a $107.00 price objective on Perrigo and gave the stock a “buy” rating in a report on Saturday. BidaskClub upgraded Perrigo from a “strong sell” rating to a “sell” rating in a report on Saturday, September 9th. Oppenheimer assumed coverage on Perrigo in a report on Thursday, September 7th. They issued an “outperform” rating and a $88.00 price objective for the company. Royal Bank of Canada reiterated a “sell” rating and issued a $64.00 price objective on shares of Perrigo in a report on Wednesday, September 13th. Finally, Canaccord Genuity reiterated a “buy” rating and issued a $100.00 price objective (up previously from $88.00) on shares of Perrigo in a report on Wednesday, September 13th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and nine have assigned a buy rating to the company’s stock. Perrigo presently has a consensus rating of “Hold” and a consensus price target of $92.13.
WARNING: “Perrigo Company (PRGO) Shares Sold by Magnetar Financial LLC” was originally published by Watch List News and is the property of of Watch List News. If you are reading this story on another domain, it was copied illegally and republished in violation of US & international trademark & copyright laws. The legal version of this story can be read at https://www.watchlistnews.com/perrigo-company-prgo-shares-sold-by-magnetar-financial-llc/1769832.html.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.